Sovaldi
Sovaldi

29.21
A generic alternative indicated for Antivirals. It targets specific proteins to manage viral load and promote long-term liver health.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Sofosbuvir
Reference Brand
Sofosbuvir
Product Origin
Generic Alternative
Reference Manufacturer
Gilead Sciences
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Infection Treatment, Infection Treatment
Product Category
Antiviral (NS5B Inhibitor)
Pharmacological Class
Direct-acting antiviral
Clinical Indications
Manufacturer Description
A nucleotide analogue intended to manage Hepatitis C infection and designed to alleviate liver inflammation by targeting viral replication to support patient recovery.
Mechanism of Action
It inhibits the Hepatitis C virus NS5B RNA-dependent RNA polymerase, which is the enzyme the virus needs to duplicate its genetic material.
Route of Administration
Oral
Onset Time
Steady state in days
Duration
24 hours
Contraindications
Allergy to sofosbuvir
Severe Adverse Events
Hepatitis B reactivation, Severe bradycardia (with amiodarone), Liver failure, Severe allergic reaction
Common Side Effects
Fatigue, Headache
Uncommon Side Effects
Nausea, Insomnia, Anemia, Pruritus (itching)
Drug Interactions
Amiodarone, Rifampin, Carbamazepine, St. John's wort, Phenytoin
Pregnancy Safety Warnings
Use only if clearly needed.
Age Restrictions
Approved for children 3 years and older.
Storage Guidelines
Store below 30°C.
Related Products
Daklinza, Epclusa
Information for Sovaldi is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
Categories